Severn Vale Home Care Cements its Position as a Sector Leader With GHP Social Care Award
04/03/2025, Worcester WR2 4AY // PRODIGY: Feature Story //
A home care team serving clients and communities in Worcester, Malvern and the surrounding areas, Severn Vale Home Care, has celebrated resounding success after being named the winner of the Global Health & Pharma (GHP) award for Most Supportive Personal & Complex Care Specialists 2024 – West Midlands.
Founded in 2020, this accolade is the latest in multiple high-profile awards received by the family-owned and operated business. It demonstrates how value-based, compassionate, and community-focused care is a recipe for rapid success.
The Importance of the GHP Social Care Awards in the Home Care Space
The GHP Social Care Awards are a prestigious and widely recognised mark of quality across the social care sector. They seek to reward, acknowledge, and celebrate companies and firms that represent the best in standards, dedication, hard work, and invaluable assistance to vulnerable people and those in critical need of support.
As part of the nomination and selection process, GHP invites people and third parties to submit suggestions. Every submission is evaluated by social care professionals to assess the nominees' achievements and quality, ensuring an objective, fair, and impartial process.
Severn Vale Home Care was nominated, finalised, and selected as the overall winner for the Most Supportive Personal & Complex Care Specialists 2024 in the region. This highly competitive accolade is decided by a judging panel comprising academic leaders and sector experts.
This particular award reflects the company's philosophy, which concentrates its efforts on ensuring that all older people and families throughout the local communities in Worcester and Malvern are supported, never left to struggle and feel safe, secure, and happy in the comfort of their homes.
The award is designed to celebrate care specialists who set the standard for providing personalised, flexible and appropriate care for people with complex care needs or health concerns and who do so in a way that embraces respect, compassion, dignity and self-advocacy.
Reflecting on Severn Vale Home Care's Success at the GHP Social Care Awards
Stuart Callister, Founding Director of Severn Vale Home Care said, ' We were delighted to be nominated and recognised in this most prestigious of awards, and particularly in a category that encapsulates all we seek to do, and the value and comfort we bring to countless people throughout the areas we serve.
Specialist and complex care is a diverse field, and we are immensely proud of our exceptional Care Professionals who never fail to go the extra mile, ensuring that people and families with potentially very complex care needs benefit from kindness, friendship and warmth as much as the practical and health-related assistance they may need.
It is fundamental that people who are potentially managing multiple challenges concerning their health, mental welfare, emotional well-being, and physical capabilities receive dedicated assistance. We step in to help wherever we can, from coordinating care visits and ongoing in-home help with other professionals to ensuring we maintain regular contact with loved ones.
When Severn Vale was founded in 2020, our ambition was to provide a local care service that would provide perfect solutions for every single person and every older individual who requires sensitive help to stay safe and happy at home. We are very grateful for both the nomination and the privilege of being selected as the award winner by the GHP panel.
The Background of the Multi-Award-Winning Severn Vale Home Care Team
Severn Vale Home Care has achieved a remarkable amount in just five years. It was founded by Stuart Callister, who decided to move back to Malvern, his home town, and find a way to give back to the local community based on the values taught by his parents.
From regular visiting and live-in home care to specialist care services, the company has established an outstanding reputation not only for quality and standards but also for the sensitive, personalised, and gentle approach it takes, from discussing care needs for older people to ensuring Care Professionals have stable, rewarding, and meaningful careers.
Alongside the GHP Social Care Award, Severn Vale has also been recognised by multiple other organisations, including being named Home Healthcare Provider of the Year in the Innovation & Excellence Awards 2024 and Home Care Business of the Year 2024 in the Worcestershire category at the SME News Seventh Annual UK Enterprise Awards.
Media Contact:
01905 950409
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
a day ago
- Medscape
Balanced Crystalloids Excel in Sepsis Fluid Resuscitation
A network meta-analysis of randomized trials found that balanced crystalloids reduced 90-day mortality more than low-molecular-weight hydroxyethyl starch and saline in patients with sepsis or septic shock and ranked highest for reducing the need for renal replacement therapy (RRT) and blood transfusion. METHODOLOGY: To compare various fluid resuscitation strategies, researchers conducted a network meta-analysis of 28 randomized controlled trials, which included 8770 patients with sepsis or septic shock (mean ages, 3-73 years). The intervention group received one or more of the following fluid supplements: Balanced crystalloids, saline, isooncotic albumin, hyperoncotic albumin, low-molecular-weight hydroxyethyl starch, high-molecular-weight hydroxyethyl starch, and gelatin. The control group received placebo or standard treatment. The study outcomes were 28-day mortality, 90-day mortality, the incidence of acute kidney injury, and the need for RRT and blood transfusions after treatment. TAKEAWAY: Balanced crystalloids reduced 90-day mortality compared with low-molecular-weight hydroxyethyl starch (risk ratio [RR], 0.84) and saline (RR, 0.89) and reduced the need for RRT compared with high-molecular-weight hydroxyethyl starch (RR, 0.59; 0.3-0.99). The surface under the cumulative ranking curve analysis showed that balanced crystalloids were the best fluid to reduce 28-day mortality (71.4%), 90-day mortality (86.3%), and the need for RRT (75.5%) and blood transfusions (72.2%). The same analysis showed that hyperoncotic albumin was the most effective in reducing the incidence of acute kidney injury (74.5%). IN PRACTICE: "In conclusion, BC [balanced crystalloids] demonstrates superiority over both L-HES [low-molecular-weight hydroxyethyl starch] and saline in reducing mortality in sepsis and septic shock patients, while Hyper-Alb [hyperoncotic albumin] is most effective in minimizing renal injury," the authors wrote. "However, given the current limitations, further high-quality, multicenter, large-sample RCTs [randomized controlled trials] are essential for more comprehensive analyses," they added. SOURCE: The study was led by Jiao Long, Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China. It was published online on June 4, 2025, in The American Journal of Emergency Medicine. LIMITATIONS: Studies examining the combination of balanced salt solutions with colloids or albumin were scarce. Variability in the doses of resuscitation fluid across studies may have affected the consistency of the findings. Additionally, the studies included in the analysis were published only in English, which may have led to selection biases. DISCLOSURES: This study was not supported by any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. The authors declared no known competing financial interests or personal relationships that could have influenced the work reported in this paper.
Yahoo
4 days ago
- Yahoo
How to Organize a Health Technology Business with Focus on 10+ Organizational Archetypes
Discover the evolving organizational structures of digital health businesses in the Pharma and MedTech sectors. This report analyzes 11 HealthTech archetypes over 15 years, offering insights on performance across key KPIs, future trends, and strategic recommendations. Featured companies include Bayer, Roche, and more. Dublin, June 09, 2025 (GLOBE NEWSWIRE) -- The "How to Organize a HealthTech Business?" report has been added to offering. This report sheds light on how to organize digital health businesses, especially at large Pharma and MedTech companies. By looking at how other companies have been managing their HealthTech businesses over the last 15 years, 11 different HealthTech organizational archetypes are being detailed out in the report, including their objectives, responsibilities, team sizes, target partner company stages, governance, value propositions for their partners, business impact evaluations across 4 KPIs and real-life examples from companies who had deployed these structures. Performance of the 11 archetypes are then evaluated and compared across the four main KPIs which are based on finding partners, launching solutions, driving usages & cultural change support. Based on the evaluation of the success and impact of these archetypes, the report presents a benchmarking table of HealthTech business organizations today. With a deep-dive into the evolving trends in HealthTech business organizations responding to the changing market conditions across three main market phases, 5 trend points for future and relevant recommendations are provided on what needs to be done to stay competitive and move forward in growing digital health market. Questions the report answers: What are the archetypes to organize HealthTech businesses at Pharma and MedTech companies? What are the different objectives and responsibilities of each organizational archetype? How are the archetypes governed at larger corporates? How does each organizational archetype perform? Which Pharma and MedTech apply which archetype to manage their HealthTech business today? How did the archetypes evolve to adept the market conditions today? What does the market require for organization of HealthTech businesses in 3-5 years? Interested parties can benefit from this report in the following ways: Consultants: gain insights into different organizational structures within the HealthTech industry, and enhance the ability to advise clients on optimal structuring and strategic alignment for digital health initiatives Strategy heads: understand how leading organizations structure their HealthTech initiatives, which can inform strategic planning and decision-making processes Business unit heads: understand how to integrate digital health solutions into the units effectively, determine the most suitable structure for the unit, and align with overall corporate objectives Digital health unit heads: benchmark your organizational structure against others, know what is needed in terms organizational structure to stay competitive in the growing digital health market, and optimize your organizational structure to foster innovation and integration with business units In this report, the following companies are mentioned: Bayer Roche Biogen Sanofi Siemens Healtineers GE Healthcare Janssen (J&J) MSD Merck KGaA Novartis Becton Dickenson and Company *30 min report consultation with a research analyst available with the purchase of an enterprise license Key Topics Covered: Archetype-1: Central Teams Archetype-2: De-Central Teams Archetype-3: Carve-Outs Archetype-4: Innovation Hubs Archetype-5: Incubators Archetype-6: Accelerators Archetype-7: Collaborative Accelerators Archetype-8: People Accelerators Archetype-9: Marketplace Organizations Archetype-10: Venture Funds Archetype-11: Outsourcing The Influence of Market Maturity on the Development of HealthTech Organizational Forms Building Successful HealthTech Teams for the Next 3-5 Years For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Medscape
4 days ago
- Medscape
WHO Resolution Aims to Bridge Global Gap in Skin Care
A medical resident in the South Pacific will soon make history. After he graduates in 2026, he's slated to become the first dermatologist to serve the Solomon Islands, a nation of 800,000 people. His training is both a breakthrough and the product of an international effort to improve access to skin care. As they gathered in Fiji in late May to support the resident's regional training program, visiting dermatologists got thrilling news: In Geneva, the World Health Organization (WHO) unanimously passed a landmark resolution to support global skin health. Dermatology trainee Joseph Sangatu, slated to become the first dermatologist in the Solomon Islands, and American dermatologist Esther Freeman, MD, PhD, in the patient ward at the Pacific Dermatology Trainin Cengter in Suva, Fiji. 'We're here 2 days after the resolution passed, already implementing it,' said Claire Fuller, a London-based consultant dermatologist and chair of the International League of Dermatological Societies (ILDS) in an interview. 'The timing is fantastic.' Addressing a Global Care Crisis The resolution aims to tackle stark disparities in global dermatological care. Africa and the Pacific islands have only zero to three dermatologists per million people, Esther Freeman, MD, PhD, associate professor of dermatology at Harvard Medical School and director of Global Health Dermatology at Massachusetts General Hospital, Boston, said in an interview from Fiji. 'Many countries have zero dermatologists. There are two dermatologists in Papua New Guinea for 10 million people,' she said. In May, at the annual meeting of the Society for Investigative Dermatology in San Diego, Freeman told colleagues about other gaps in care: In parts of Africa, people with albinism can't find sunscreen, and moisturizer for atopic dermatitis costs double the typical monthly salary. In Australia, only six dermatologists serve rural areas. At least a billion patients with skin disease have no access to dermatologic care, she said, and many more can't afford it. The WHO's 'Skin Diseases as a Global Public Health Priority' resolution, proposed by the Ivory Coast and backed by Nigeria, Togo, Micronesia, and China, aims to implement a coordinated global strategy through initiatives like Fiji's regional training program. The resolution, which passed without the support of the absent US delegation, doesn't come with funding. But José Ruiz Postigo, MD, PhD, a Neglected Tropical Diseases medical officer with WHO, told Medscape Medical News from Fiji that the vote is still transformative. A resolution comes with a high level of mandate, he said. 'When you approach someone at a ministry of health and they ask why you are doing this, to what extent is this a priority, you show them the resolution.' What Will the Resolution Do? One goal of the resolution is to boost the training of dermatologists around the world through programs such as the Fiji's Pacific Dermatology Training Center . It's the first dermatology training program ever established in the Pacific islands, and three Fijians are graduating as the region's inaugural dermatologists. The center, supported by a 5-year ILDS agreement, is similar to programs that have been implemented in other parts of the world. A regional center in Tanzania, for example, serves 16 countries across Africa. Fuller emphasized that training isn't just a matter of producing dermatologists: '80% of dermatology burden is caused by about 10 diseases. We've got an achievable curriculum, and we can train community frontline workers on these 10 diseases.' Freeman agreed, noting that a focus on 10 diseases is 'much more manageable . ' 'We definitely need dermatologists to train the trainers, but they're not the only key players. We'll never have enough dermatologists,' she said. 'Using Papua New Guinea as an example, we need to acknowledge who's on the ground. It could be nurses, medical officers, pharmacists. There's a lot of different cadres of health workers, and this gives us an opportunity to think about the big picture of how we treat people on the front line.' Funding Isn't Allocated — But It's Encouraged Even though it doesn't allocate funding, the resolution specifically recommends that member states increase investment and financing for skin health. 'We in the dermatology community can go to WHO members and say, 'You signed up for this resolution, how can we help you deliver it?'' Fuller said. 'We're not waiting for governments to just act on this; we're going to help them do it.' In addition, the resolution 'opens the door' toward nongovernmental funding, she said. 'Everyone can go to a donor, a university, and say 'Look, in view of this resolution, we want to do this, but we need money.' It's something concrete to point to.' The resolution also mandates WHO to develop internal dermatological resources. 'There's no dermatology department,' Fuller added. 'An obvious solution is to develop a dermatological resource within WHO.' As for the ultimate goal, she said, 'we'd like to be able to say that access to dermatological care is a standard: Any person with a common skin disease would be able to go to their frontline healthcare provider and get it addressed, and there would be specialist services available to refer to when needed.'
